165 related articles for article (PubMed ID: 6313197)
21. Tc-99m pyrophosphate myocardial imaging in acute myocardial infarction: value and limitations.
Ahmad M
Mo Med; 1981 Sep; 78(9):575-8. PubMed ID: 6273708
[No Abstract] [Full Text] [Related]
22. [Contribution of cardiac scintigraphy with technetium Tc 99m pyrophosphate and of determination of the ventricular ejection fraction to evaluation of non-transmural acute myocardial infarct].
Roncari G; Casucci R; Garancini S; Ballada L; Verna E; Bonelli R
Boll Soc Ital Cardiol; 1981; 26(12):2359-63. PubMed ID: 6309199
[No Abstract] [Full Text] [Related]
23. [Pyrophosphate scan of the heart in cardiomyopathies (author's transl)].
Duska F; Novák J; Kubícek J; Vizda J; Kafka P; Blaha V; Nesvadba Z; Zdánský P
Cesk Radiol; 1982 Jan; 36(1):40-7. PubMed ID: 6284387
[No Abstract] [Full Text] [Related]
24. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
25. Effect of EHDP on calcium accumulation and technetium-99m pyrophosphate uptake in experimental myocardial infarction.
Buja LM; Tofe AJ; Parkey RW; Francis MD; Lewis SE; Kulkarni PV; Bonte FJ; Willerson JT
Circulation; 1981 Nov; 64(5):1012-7. PubMed ID: 6269777
[No Abstract] [Full Text] [Related]
26. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
[No Abstract] [Full Text] [Related]
27. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
Fogelman I; Bessent RG
Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
[No Abstract] [Full Text] [Related]
28. [5 years of pyrophosphate scanning of the heart. A set of results from clinical practice].
Duska F; Novák J; Vizda J; Kafka P; Kubícek J; Veverková O
Cas Lek Cesk; 1982 Aug; 121(33):1043-6. PubMed ID: 6290068
[No Abstract] [Full Text] [Related]
29. Experimental studies of the myocardium by 99mTc-pyrophosphate scanning.
Sheiretova E; Marinov V; Stoyanova M; Ivanov Z; Kaloyanova A; Kovacheva S
Radiol Diagn (Berl); 1979 Dec; 20(6):869-75. PubMed ID: 549071
[No Abstract] [Full Text] [Related]
30. Myocardial accumulation of 99Tcm-pyrophosphate and 99Tcm-gluconate compared with morphologic findings in daunorubicin treated rabbits.
Ahlberg NE; Paul C; Isberg B; Rajs J; Svahn U
Acta Radiol Diagn (Stockh); 1982; 23(5):463-70. PubMed ID: 6297245
[TBL] [Abstract][Full Text] [Related]
31. Technetium pyrophosphate labelling following catheter shock: potential for a new intraoperative mapping technique.
Yao LC; Humen DP; Shnitka TK; Trask K; Jugdutt BI
Can J Cardiol; 1987 Oct; 3(7):326-33. PubMed ID: 2827870
[TBL] [Abstract][Full Text] [Related]
32. [Estimation of the prognosis of patients with ischemic heart disease with the aid of pyrophosphate scanning of the heart muscle].
Duska F
Vnitr Lek; 1982 Nov; 28(11):1109-13. PubMed ID: 6297166
[No Abstract] [Full Text] [Related]
33. [Scintiscan diagnosis of acute myocardial infarction using 99mTc-labelled gluconate (author's transl)].
Duska F; Novák J; Vizda J; Kafka P
Cas Lek Cesk; 1982 Apr; 121(15):458-61. PubMed ID: 7083290
[No Abstract] [Full Text] [Related]
34. Infarct sizing with Tc-99m pyrophosphate.
Bianco JA
J Nucl Med; 1982 Oct; 23(10):939-40. PubMed ID: 6288900
[No Abstract] [Full Text] [Related]
35. [The importance of the current use of pyrophosphate scintigraphy and other noninvasive methods in the detection of cardiac damage in systemic lupus erythematosus].
Duska F; Bradna P; Pospísil M; Kubícek J; Vizda J; Kafka P; Palicka V; Mazurová Y
Cas Lek Cesk; 1986 Sep; 125(38-39):1216-9. PubMed ID: 3022930
[No Abstract] [Full Text] [Related]
36. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
37. Technetium-99m pyrophosphate scintigraphy in a patient with malignant hyperthermia.
Murakawa M; Hatano Y; Mori K; Torizuka T; Tamaki N; Iwasaki R
J Nucl Med; 1989 May; 30(5):718-9. PubMed ID: 2541229
[No Abstract] [Full Text] [Related]
38. Technetium-99m pyrophosphate in diagnosis of acute cardiac rejection in the rat with effect of cyclosporine: concise communication.
McGregor CG; Hatz R; Aziz S; Billingham MB; McDougall IR
J Nucl Med; 1984 Aug; 25(8):870-3. PubMed ID: 6086860
[TBL] [Abstract][Full Text] [Related]
39. Myocardial uptake of technetium-99m pyrophosphate in systemic amyloidosis.
Ptacin MJ
Am J Cardiol; 1984 Oct; 54(7):938-9. PubMed ID: 6091435
[No Abstract] [Full Text] [Related]
40. [Preliminary clinical use of radionuclide myocardial imaging (author's transl)].
Liu XJ; Shi RF; Guo XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep; 8(3):169-73. PubMed ID: 6273094
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
